{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SER.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SER.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SER.AU\",,,,,undefined,":{"symbol":"SER.AU","market":"AU","secType":"STK","nameCN":"STRATEGIC ENERGY RESOURCES","latestPrice":0.006,"timestamp":1744870320000,"preClose":0.007,"halted":0,"volume":40000,"delay":0,"nameEN":"STRATEGIC ENERGY RESOURCES","floatShares":360250685,"shares":671033330,"eps":-0.003101,"marketStatus":"Not Yet Opened","change":-0.001,"latestTime":"04-17 16:12:00 AEST","open":0.006,"high":0.006,"low":0.006,"amount":240,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.003101,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.007,"openAndCloseTimeList":[[1744848000000,1744869600000]],"volumeRatio":0.038118711955286946,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SER.AU\",,,,,undefined,":{"symbol":"SER.AU","floatShares":360250685,"roa":"-9.88%","roe":"-23.46%","lyrEps":-0.003067,"volumeRatio":0.038118711955286946,"shares":671033330,"dividePrice":0,"high":0.006,"amplitude":0,"preClose":0.007,"low":0.006,"week52Low":0.004,"pbRate":"0.52","psRate":"88.42","week52High":0.035,"institutionHeld":0,"latestPrice":0.006,"eps":-0.003101,"divideRate":0,"volume":40000,"delay":0,"ttmEps":-0.003101,"open":0.006,"prevYearClose":0.007,"prevWeekClose":0.006,"prevMonthClose":0.005,"prevQuarterClose":0.005,"fiveDayClose":0.006,"twentyDayClose":0.006,"sixtyDayClose":0.007},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SER.AU\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SER.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526823927","title":"Serina Therapeutics Raises $5 Million for Clinical Development of Parkinson's Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2526823927","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526823927?lang=en_us&edition=fundamental","pubTime":"2025-04-09 04:45","pubTimestamp":1744145131,"startTime":"0","endTime":"0","summary":"Serina Therapeutics  said Tuesday that it raised $5 million in financing from shareholders, which will be utilized to support the development of POZ-apomorphine to treat Advanced Parkinson's disease.The phase 1 clinical trial of the candidate is expected to commence in Q4, the company said.The company raised the financing by issuing 965,250 shares of convertible preferred stock at $5.18 per share.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4139","SER.AU","SER","LENZ","BK7095"],"gpt_icon":0},{"id":"2518763608","title":"LPM progresses through Bynoe lithium development activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2518763608","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518763608?lang=en_us&edition=fundamental","pubTime":"2025-03-11 13:57","pubTimestamp":1741672620,"startTime":"0","endTime":"0","summary":"Lithium Plus Minerals Ltd  has ticked off a suite of development activities at its 4.09 million-tonne Bynoe Lithium Project in the Northern Territory, including metallurgical testing, planning for its mine and crucial infrastructure, and discussions about offtake.The project – located close to Darwin – is built around the Lei deposit, which carries a mineral resource estimate  of 4.09 million tonnes at 1.43% Li2O , numbers which LPM believes put it among the top deposits for this commodity in Australia.Development activity also sought to boost and define the quality of the resource. This included a 51% uplift in head-grade  at 57.8% mass yield for 87% lithia recovery – achieved through ore sorting trails – which allowed for the reduction of about 42% of low-grade material into a waste stream.LPM has also conducted metallurgical test work on the ore, achieving 85.3% recovery to a concentrate of 6.12% Li2O from DMS and fines and middlings flotation on a high-grade sample.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/lpm-progresses-through-bynoe-lithium-development-activities-2025-03-11/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["TIA.AU","MRE.AU","SER","BK7507","BK7509","BK7095","LPM.AU","SER.AU","BK7145","BK4139","PLS.AU","BK7504"],"gpt_icon":0},{"id":"2503396399","title":"Strategic Energy Resources Says Surveys Identify Drilling Targets at Queensland Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2503396399","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503396399?lang=en_us&edition=fundamental","pubTime":"2025-01-16 13:23","pubTimestamp":1737004989,"startTime":"0","endTime":"0","summary":"Strategic Energy Resources  said ground gravity and drone magnetic surveys, combined with machine learning models, have refined drill targets at the Nardoo copper-gold site at its Isa North project in Queensland, according to a Thursday filing with the Australian bourse.Four geophysical targets have been highlighted as high-priority, it said.Site preparations were completed ahead of the proposed drill program and site visits to assess the area are imminent in anticipation of earthworks for drilling to commence in mid-2025, the filing added.The firm's shares rose over 14% on market close.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SER.AU","BK7095"],"gpt_icon":0},{"id":"2503770966","title":"Serina Therapeutics Sells UniverXome Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2503770966","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503770966?lang=en_us&edition=fundamental","pubTime":"2025-01-16 05:20","pubTimestamp":1736976041,"startTime":"0","endTime":"0","summary":"Serina Therapeutics  said Wednesday it sold its UniverXome subsidiary.The deal, which was finalized on Dec. 23, cut $11.2 million in associated subsidiary-level debt, Serina said, adding it now has a debt-free balance sheet.The unit was set up before Serina's reverse merger with AgeX Therapeutics in March 2024 to hold the legacy assets of the predecessor company, Serina said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","SER","BK4139","LENZ","SER.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SER.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-08-26","symbol":"SER.AU","defaultRemindTime":1598400000000,"type":"split","dateTimestamp":1598364000000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SER.AU\",market:\"AU\",,,undefined,":[]}}